サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：合成生物学の世界市場-2023-2030
市場調査レポート
商品コード
1217643

合成生物学の世界市場-2023-2030

Global Synthetic Biology Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 200 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.94円
合成生物学の世界市場-2023-2030
出版日: 2023年02月14日
発行: DataM Intelligence
ページ情報: 英文 200 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場概要

工学的原理を生物学に応用することが、合成生物学という新たな学際分野の焦点となっています。合成生物学は、自然界に存在しない生物学的システムや部品を（再）設計および製造することを目的としています。合成生物学を利用すれば、研究者はカタログに載っているDNA配列を素早く作り出し、新しいゲノムを組み立てることができます。合成生物学は、DNAの化学合成と拡大するゲノミクスの知識を組み合わせたものです。科学者は現在、DNA合成のスピードとコストが向上したことにより、改良型バイオ燃料、バイオ製品、再生可能化学品、バイオベースの特殊化学品の製造や、ヘルスケア産業で使用できる改良型細菌染色体を作り出すことができるようになったのです。

市場力学

合成生物学の世界市場を牽引する主な要因は、主要企業が市場を牽引するための戦略的投資を行うこと、診断や技術の向上、サポートすることなどが予想されます。タンパク質治療、個別化医療、合成医薬品やワクチンの研究などの需要の高まりを受けて、市場の上昇が予想されます。

主要企業が戦略的な投資を行うことが、市場の成長を促進すると予想されます。

現在、新薬の研究開発のために、製薬会社にはより多くの資金が割り当てられています。さまざまな製薬会社やバイオテクノロジー企業に助成金を支給する政府プログラムにより、栄養補助食品や瞑想の研究が促進されています。

合成生物学に対する社会の認識が変われば、合成生物学製品の市場は上昇します。その結果、市場の主要企業は、企業を成長させ需要を満たすために、買収や共同研究などの活動を通じて戦略的な開拓に投資しています。例えば、合成生物学のプレミアスタートアップであるCodexis, Inc.と有名なライフサイエンス投資家であるCasdin Capitalによって、2020年11月にSynBio Innovation Acceleratorが導入されました。日本の大手企業である住友化学は、合成生物学に基づく次世代ビジネスの育成を意図して、米国に新会社「SynBio Hub」を設立しました。

2020年の合成生物学業界のスタートアップ企業への投資額は78億米ドル、2021年には180億米ドルに達しています。DNA ScriptやArbor Biotechnologiesといった企業は、それぞれ約2億1500万米ドル、1億6720万米ドルの資金を調達しました。多額の投資は、市場を通じた資金の流れを促進し、サプライチェーンに沿った事業の拡大を助ける。

市場の拡大は、安全性の懸念が妨げになる可能性が高いです。

しかし、遺伝子組換え生物の意図的または非意図的な環境への放出は、人々と生態系の両方に有害な影響を与える可能性があります。その結果、市場の拡大が阻害されることが予想されます。

COVID-19影響度分析

合成生物学製品の利用は、COVID-19の発生により、この2年間で拡大しました。COVID-19の検査キット、治療法、予防接種を作成するための新しい方法を使用することで、多くの大手製薬・バイオテクノロジー企業や合成生物学業界の参加者は、世界的に研究活動を強化しました。欧州議会の調査によると、合成生物学は新たな技術の一つです。COVID-19感染症対策に応用できます。また、米国の国立衛生研究所は、ワクチンの作成を早めるために合成生物学を利用することに着目しています。

合成生物学は、初歩的な学術的試みから、部分的に産業化された堅実な戦略へと発展しています。COVID-19が大流行した際、合成生物学がもたらす生物医学上の可能性はかつてないほど明らかになりました。研究の進展からワクチン、治療薬、診断薬の迅速な開発まで、この分野は世界規模の大惨事において大きな貢献をしています。DNAやRNAの合成など、多くの合成生物学のプロセスを自動化することは、この重要な分野を発展させる上で極めて重要です。合成生物学の勢いに乗り、その利点をがん、代謝疾患、遺伝子疾患などの感染症以外の分野にも拡大するためには、現在の自動化プラットフォームを改善し、まだ手作業で行われている段階の自動化を継続する必要があります。

目次

第1章 調査手法と調査範囲

  • 調査手法
  • 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場影響要因
    • 促進要因
      • 主要企業が市場を牽引するための戦略的投資を行うことが予想されます。
      • 診断と技術の向上別支援
    • 抑制要因
      • 安全性への懸念が市場拡大の妨げとなる可能性が高いです。
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • プライシング分析
  • 規制分析

第6章 COVID-19の分析

  • COVID-19の市場分析
    • COVID-19以前の市場シナリオ
    • COVID-19の現在の市場シナリオ
    • COVID-19の後、または将来のシナリオ
  • COVID-19の中での価格ダイナミクス
  • 需要-供給スペクトラム
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的取り組み
  • まとめ

第7章 製品タイプ別

  • コア製品
    • 合成遺伝子
    • 合成DNA
    • 合成細胞
    • シャーシ生物
    • その他
  • 実現可能な製品
    • オリゴヌクレオチド合成
    • DNA合成

第8章 技術別

  • 遺伝子合成
  • ゲノムエンジニアリング
  • 塩基配列決定
  • バイオインフォマティクス
  • クローニング
  • 部位特異的変異導入
  • 計測・モデリング
  • マイクロフルイディクス

第9章 アプリケーション別

  • ヘルスケア
  • 食品・農業
  • 化学物質
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第11章 競合情勢

  • 主な展開と戦略
  • 企業シェア分析
  • 製品ベンチマーク
  • 注目の主要企業リスト

第12章 企業プロファイル

  • Amyris Inc
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • Algenol Biofuels Inc.
  • Bayer AG
  • CBC Comprehensive Biomarker Center GmbH
  • Bristol-Myers Squibb
  • Biosearch Technologies Inc.
  • Gene Script Corporation
  • GeneWorks Pty Ltd.
  • DuPont Inc.
  • Thermo Fisher Scientific In.

第13章 世界の合成生物学市場-DataM

目次
Product Code: DMBT2364

Market Overview

The global synthetic biology market size was valued at US$ XX million in 2022 and is estimated to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period (2023-2030).

The application of engineering principles to biology is the focus of the emerging interdisciplinary field of synthetic biology. It aspires to create biological systems and parts that do not already exist in the natural world through (re-)design and fabrication. With the help of synthetic biology, researchers can quickly produce cataloged DNA sequences and assemble them into new genomes. Synthetic biology combines the chemical synthesis of DNA with expanding genomics knowledge. Scientists are now able to create modified bacterial chromosomes that can be employed in manufacturing improved biofuels, bioproducts, renewable chemicals, and bio-based specialty chemicals, as well as in the healthcare industry, due to advancements in the speed and cost of DNA synthesis.

Market Dynamics

The major factors driving the global synthetic biology market the key companies are anticipated to make strategic investments to drive the market, improved diagnosis and techniques to support. The market is anticipated to rise in response to the rising demand for protein therapies, individualized medicine, and research into synthetic drugs and vaccines.

Key companies are anticipated to make strategic investments is expected to drive the market's growth.

More funding is now being allocated to pharmaceutical companies for research and development to find new medications. Government programs subsidizing various pharma and biotech companies have promoted research into dietary supplements and meditation.

The market for synthetic biology products rises as societal perceptions of synthetic biology change. As a result, major market players invest in strategic development through activities like acquisition, collaboration, etc., to grow their companies and meet demand. For instance, the SynBio Innovation Accelerator was introduced by premier synthetic biology start-up Codexis, Inc. and a renowned life science investor, Casdin Capital, in November 2020. One of the major players in Japan, Sumitomo Chemical, established SynBio Hub, a new company in the U.S., intending to foster the development of synthetic biology-based next-generation businesses.

In 2020, investments in start-ups in the synthetic biology industry totalled $7.8 billion, and in 2021, they reached $18.0 billion. Companies like DNA Script and Arbor Biotechnologies raised about 215 million and 167.2 million dollars, respectively. The significant investment promotes the flow of money through the market and aids in the expansion of businesses along the supply chain.

The market's expansion will likely be hampered by safety concerns.

However, the intentional or unintentional release of genetically modified organisms into the environment could have detrimental effects on the health of both people and the ecosystem. In consequence, it is anticipated that this will impede market expansion.

COVID-19 Impact Analysis

The use of synthetic biology products has expanded during the last two years due to the COVID-19 outbreak. By using novel methods for creating test kits, treatments, and vaccinations for COVID-19, many major pharmaceutical and bioTechnologies businesses and synthetic biology industry participants have intensified their research operations globally. Synthetic biology is one of the emerging technologies, according to a study from the European Parliament. It can be applied to the fight against COVID-19 infection. The National Institute of Health in the U.S. has also highlighted the use of synthetic biology to hasten the creation of vaccines.

Synthetic biology has evolved from a rudimentary academic endeavor to a solid, partially industrialized strategy. During the COVID-19 pandemic, the biomedical opportunities provided by synthetic biology have never been more apparent: from advancing research to enabling quicker development of vaccines, therapeutics, and diagnostics, this discipline has made great contributions during a worldwide catastrophe. Automating the many synthetic biology processes, such as DNA and RNA synthesis, has been crucial to developing this significant field. Building on the momentum of synthetic biology and extending its advantages to areas beyond infectious diseases, such as cancer, metabolic, and genetic disorders, companies would need to improve the present automation platforms and carry on with the automation of stages that are still done manually.

Segment Analysis

The healthcare segment is expected to grow at the fastest CAGR during the forecast period (2023-2030)

The application segment is the highest market holder in the global synthetic biology market. The quick advancement of synthetic biology has driven the healthcare segment in terms of the various treatment techniques utilizing designed phages, artificial cells, and live bacteria.

For instance, it has made it possible for life technologies to create antigens and variants with high expression, quick outcomes, and capacity. Applications for synthetic biology range from the creation of drugs and vaccines to the production of products and diagnostic procedures.

Researchers use rational engineering methods to create unique, dynamic biosensing systems composed of a processor, sensor, and reporter. A growth in neurological diseases like multiple sclerosis is also fueling this market. For instance, starting in July 2022, synthetic biology specialists at the University of Toronto Engineering are creating personalized stem cells from patient tissues to treat ailments. These research initiatives are expected to support segment growth. Additionally, several initiatives performed by governments and other organizations are anticipated to benefit the market for research in this segment.

Geographical Analysis

North America holds the largest market share in the global synthetic biology market.

North America dominates the global Synthetic Biology market primarily due to its large population, excellent medical infrastructure, and high-income levels. Due to the expanding demand for bio-based products, rising investments in synthetic biology businesses, and rising R&D funding for synthetic biology, North America is predicted to have the greatest proportion of the global market for synthetic biology. as a result of greater government support, favorable laws, and increased investment in the development of synthetic biological products. In the first half of 2020, businesses in this industry, including Moderna Therapeutics, Sana BioTechnologies, Poseida Therapeutics, Apeel Sciences, and Greenlight Biosciences, raised more than $3 billion in financing.

Proteomics, genomic structure prediction, and drug development research are highly valued in the U.S., which is good for the synthetic biology sector. Additionally, certain for-profit businesses like the Gates and Melinda Foundation and government-funded research institutions like the National Institutes of Health (NIH) are promoting synthetic biology research and development, which could improve the chances for the nation's economic development. Additionally, growing funding from public and private organizations and R&D expenditures on drug development are significant growth factors anticipated to propel the market throughout the forecast period.

Competitive Landscape

The Synthetic Biology market is moderately competitive with local and global companies' presence Amyris Inc., Algenol Biofuels Inc., Bayer AG, CBC Comprehensive Biomarker Center GmbH, Bristol-Myers Squibb, Biosearch Technologies Inc., Gene Script Corporation, GeneWorks Pty Ltd., DuPont Inc., Thermo Fisher Scientific In and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in July 2021, addition to announcing the expansion of their research partnership, Codexis, Inc. and Kalsec, Inc. also signed a unique supply arrangement for a novel enzyme that will be used to create Kalsec's newest natural hop acid.

Thermo Fisher Scientific Inc.

Overview: In order to meet the demands of difficult analytical problems in research, diagnostics, and clinical laboratories, Thermo Fisher Scientific Inc. (Thermo Fisher) offers medical equipment, analytical instruments, reagents and consumables, software, and services. It provides answers for flow cytometry, synthetic biology, and cellular biology. The company offers a variety of goods, including as technologies for protein and molecular biology research, electron microscopy, mass spectrometry, and genetic sequencing. The business provides services to academic and research institutions, government agencies, pharmaceutical and biotech firms, clinical diagnostic laboratories, environmental, industrial quality, and process control sectors.

Product Portfolio:

Invitrogen GeneArt Gene Synthesis Services: Getting unique DNA constructions with 100% sequence fidelity is easy and affordable with GeneArt Custom Gene Synthesis. The company offers optimization using the patented GeneOptimizer algorithm, which uses a special multifactorial strategy that goes beyond codon optimization, to maximize the expression of synthetic genes.

The global Synthetic Biology market report would provide access to approx.: 45+ market data table, 40+ figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Key companies are anticipated to make strategic investments to drive the market.
      • 4.1.1.2. Improved diagnosis and techniques to support.
    • 4.1.2. Restraints:
      • 4.1.2.1. The market's expansion will likely be hampered by safety concerns.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis
  • 5.4 Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Core Product
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
      • 7.2.2.1. Synthetic Genes
      • 7.2.2.2. Synthetic DNA
      • 7.2.2.3. Synthetic Cells
      • 7.2.2.4. Chassis Organisms
      • 7.2.2.5. Others
  • 7.3. Enabling Product
      • 7.3.1.1. Oligonucleotide Synthesis
      • 7.3.1.2. DNA Synthesis

8. By Technologies

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technologies
    • 8.1.2. Market Attractiveness Index, By Technologies
  • 8.2. Gene Synthesis
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 8.3. Genome Engineering
  • 8.4. Sequencing
  • 8.5. Bioinformatics
  • 8.6. Cloning
  • 8.7. Site-Directed Mutagenesis
  • 8.8. Measurement & Modeling
  • 8.9. Microfluidics

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Healthcare
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 9.3. Food & Agriculture
  • 9.4. Chemicals
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technologies
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technologies
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technologies
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technologies
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technologies
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Products Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. Amyris Inc
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Algenol Biofuels Inc.
  • 12.3. Bayer AG
  • 12.4. CBC Comprehensive Biomarker Center GmbH
  • 12.5. Bristol-Myers Squibb
  • 12.6. Biosearch Technologies Inc.
  • 12.7. Gene Script Corporation
  • 12.8. GeneWorks Pty Ltd.
  • 12.9. DuPont Inc.
  • 12.10. Thermo Fisher Scientific In.

LIST NOT EXHAUSTIVE

13. Global Synthetic Biology Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Application
  • 13.3. Contact Us